The global point of care testing market is projected to grow from USD 42 billion in 2025 to USD 64.8 billion by 2031, ...

Advanced screenings and longevity assessments are gaining traction in preventive health. But the value is more nuanced, according to Mayo Clinic’s Dr. Liz Gilman. In this Q&A, she shares where these ...

Agilent Technologies got approval to expand the use of a cancer test to additional tumor types from the Food and Drug Administration.

As cancer screening continues to evolve, health systems are navigating a rapidly expanding toolkit of diagnostics from established stool-based tests to blood-based multi-cancer early detection (MCED) ...

Health experts are now recommending that people take a new blood test for cholesterol, which can be a key indicator for risk of heart disease. The test for heightened levels of Lipoprotein(a) — or ...

For decades, assessing cholesterol risk has been built around a simple idea: Lower “bad” cholesterol, lower your chance of a heart attack. The test at the center of that approach measures how much low ...

Share on Pinterest A new study suggests that not only is apoB testing effective for guiding cholesterol treatment, but also cost-effective. Image credit: aire images/Getty Images A study suggests that ...

“Shifting the paradigm toward proactive prevention strategies earlier in life can meaningfully change the trajectory of cardiovascular disease and lead to better health outcomes for people decades ...

Specialized chatbots might make a difference for people with limited health-care access. Without more testing, we don't know if they’ll help or harm. Earlier this month, Microsoft launched Copilot ...

A social media post from the US Food and Drug Administration this week shows a big-eyed macaque staring out from behind bars. “Some drugs use 144 monkeys on average for preclinical testing,” the post ...